Categories Breaking News, Health Care
TRxADE Health changes its name to Scienture Holdings
The stock trades on the Nasdaq Stock Market under the new symbol SCNX
Trxade Health, Inc. (NASDAQ: MEDS), a leading health services IT company, and its wholly owned subsidiary Scienture, LLC revealed that Trxade has changed its name to Scienture Holdings, Inc. Now, the stock trades on the Nasdaq Stock Market under the new ticker symbol SCNX.
Scienture Holdings, through its subsidiaries Scienture and Integra Pharma Solutions, operates as a comprehensive pharmaceutical product company, offering specialty products to satisfy unmet market needs. Its products are in development across therapeutic areas and indications, serving different market segments and channels. Scienture Holdings will be led by Suren Ajjarapu, who has been serving Trxade as chief executive officer. Suren is also chairman of the board of directors.
In July this year, Trxade completed its business combination with Scienture in a $103-million deal. Under the all-stock transaction, the company acquired all of Scienture’s assets in exchange for shares of Trxade’s stock.
Scienture, LLC is a New York-based pharmaceutical company with strategic capabilities across R&D, manufacturing, sales & marketing, and commercial operations. Last month, Narasimhan Mani was appointed as Scienture’s president. Rahul Surana was promoted to executive vice president and chief operating officer of the company.
Integra Pharma Solutions is a pharmaceutical supplier with expertise in product distribution across all key healthcare markets including government organizations, hospitals, clinics, and independent pharmacies.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Paychex expected to report higher revenue and earnings for Q2 FY26
Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal operations and client-facing services. Entering fiscal 2026, the
Signet Jewelers (SIG): A look at the progress made on Grow Brand Love
Shares of Signet Jewelers Limited (NYSE: SIG) fell over 3% on Tuesday. The stock has gained 3% year-to-date. The jewelry retailer delivered strong results for the third quarter of 2026,
Everything you need to know about Medline’s IPO
After a modest start to the year, IPO activity rebounded in the second half of the year as recession fears eased and investor confidence increased. Medical supply company Medline Inc.
